“Efficacy and safety of topical mometasone furoate 0.01% vs. tacrolimus 0.03% and mometasone furoate 0.01%in vitiligo” (2016) Journal of Pakistan Association of Dermatologists, 20(2), pp. 89–92. doi:10.66344/jpad.v20i2.427.